Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.124.002272Source: DataRank Database

Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.69)OA: bronzeTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Alexander Pilski,Shayne D. Hastings ORCID,Chris Krook-Magnuson ORCID,Steven M. Graves ORCID,Esther Krook‐Magnuson ORCID

Live enrichment

PubMed:39060163 PMC:PMC11413936 OpenAlex:https://openalex.org/W4401014446

NIDA NIH HHS

Grant: F31 DA054779

NIDA NIH HHS

Grant: R01 DA051450

NIDA NIH HHS

Grant: R37 DA007304

NIDA NIH HHS

Grant: T32 DA007304

NIDA NIH HHS

Grant: R01 DA007304

NIA NIH HHS

Grant: R01 AG070962

NINDS NIH HHS

Grant: R01 NS112518

FWCI

0.69

Citation Percentile

0.7%

Citation Trend

2025

2026

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttps://jpet.aspetjournals.org/content/jpet/early/2024/07/26/jpet.124.002272.full.pdf

publisherhttps://jpet.aspetjournals.org/content/jpet/early/2024/07/26/jpet.124.002272.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022356524177890?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022356524177890?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/jpet.124.002272

Fields of Study

HIV Research and TreatmentAdvanced biosensing and bioanalysis techniquesAlzheimer's disease research and treatmentsAnimalsLevetiracetamMiceMice, TransgenicMaletat Gene Products, Human Immunodeficiency VirusPiracetamCognitionAIDS Dementia ComplexDisease Models, AnimalAnticonvulsantsHIV-1HippocampusHumansSeizuresNeuronal PlasticityMice, Inbred C57BLExcitatory Postsynaptic PotentialsSynaptic Transmission

MeSH Terms

LevetiracetamAnimalsAnticonvulsantsCognitionDisease Models, AnimalHippocampusHumansMaleMice, Inbred C57BLMice, TransgenicSynaptic TransmissionNeuronal PlasticityPiracetamSeizuresHIV-1AIDS Dementia ComplexExcitatory Postsynaptic PotentialsMicetat Gene Products, Human Immunodeficiency Virus

Keywords

NeuroscienceLevetiracetamLong-term potentiationSynaptic plasticityCognitive deficitEpilepsyNeurotoxicityNeurocognitivePsychologyMedicineCognitionInternal medicineCognitive impairment

Sustainable Development Goals

SDG 0: Good health and well-being